Giyaan Pharma Profile
Key Indicators
- Authorised Capital ₹ 3.20 Cr
as on 05-07-2024
- Paid Up Capital ₹ 3.20 Cr
as on 05-07-2024
- Company Age 32 Year, 5 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 39.10 Cr
as on 05-07-2024
- Satisfied Charges ₹ 25.40 Cr
as on 05-07-2024
About Giyaan Pharma
The Corporate was formerly known as M.K. Organics Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.20 Cr and a paid-up capital of Rs 3.20 Cr.
The company currently has active open charges totaling ₹39.10 Cr. The company has closed loans amounting to ₹25.40 Cr, as per Ministry of Corporate Affairs (MCA) records.
Prasada Kambham, Punugoti Reddy, and Spoorthi Kambam serve as directors at the Company.
- CIN/LLPIN
U24100TG1992PTC015124
- Company No.
015124
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Dec 1992
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Giyaan Pharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Prasada Kambham  | Managing Director | 10-Jul-2017 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Punugoti Reddy | Whole-Time Director | 25-Jan-2001 | Current |
| Spoorthi Kambam | Director | 10-Jul-2017 | Current |
Financial Performance and Corporate Structure Insights of Giyaan Pharma.
Giyaan Pharma Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Giyaan Pharma?
Unlock access to Giyaan Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Gaudium Educational Services Private LimitedActive 11 years 3 monthsSpoorthi Kambam is a mutual person
Greenmark Developers Private LimitedActive 18 years 5 monthsPrasada Kambham and Spoorthi Kambam are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 19 Jul 2023 | ₹28.18 Cr | Open |
Others Creation Date: 13 Jul 2018 | ₹10.92 Cr | Open |
Others Creation Date: 13 Jul 2020 | ₹1.95 Cr | Satisfied |
How Many Employees Work at Giyaan Pharma?
Giyaan Pharma has a workforce of 84 employees as of Mar 26, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Giyaan Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Giyaan Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
